Walgreens Boots Alliance, Inc. which can be found using ticker (WBA) have now 17 market analysts covering the stock. The analyst consensus now points to a rating of ‘hold’. The range between the high target price and low target price is between $41.28 and $18.35 calculating the mean target share price we have $23.74. (at the time of writing). Now with the previous closing price of $20.82 and the analysts are correct then we can expect a percentage increase in value of 14.0%. Also worth taking note is the 50 day moving average now sits at $22.24 while the 200 day moving average is $24.62. The market cap for the company is 17.84B. The stock price for the company is currently $20.69 USD
The potential market cap would be $20,344,973,587 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 31.35, revenue per share of $165.00 and a 1.32% return on assets.
Walgreens Boots Alliance, Inc. is an integrated healthcare, pharmacy and retailing company. The Company operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The Company’s U.S. Retail Pharmacy segment includes the Walgreens business, which includes the operations of retail drug stores, health and wellness services, and specialty and home delivery pharmacy services, and its equity method investment in AmerisourceBergen. Its International segment consists of pharmacy-led health and beauty retail businesses outside the United States and a pharmaceutical wholesaling and distribution business in Germany. Its portfolio of consumer brands include Walgreens, Boots, Duane Reade, the No7 Beauty Company, Benavides in Mexico and Ahumada in Chile. Its U.S. Healthcare segment is a consumer-centric, technology-enabled healthcare business that engages consumers through a personalized, omni-channel experience across the care journey.
